FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jun Nakamura

Research Profile

Disorders

Chemicals & Drugs

Physiology

Geographic Areas

Japan

Concepts & Ideas

Living Beings

Young Adult

Procedures

Case Control Studies

Co-author Network

Publications

TOP 3
Reiji Yoshimura; Jun Nakamura
[Nicotine dependence and its molecular pharmacology].
Atsuko Ikenouchi-Sugita; Asuka Katsuki; Hikaru Hori; Kazuyoshi Saito; Yoshiya Tanaka; Wakako Umene-Nakano; Reiji Yoshimura; Jun Nakamura
Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Atsuko Ikenouchi-Sugita; Hikaru Hori; Mayumi Sakaue; Kazunari Sugita; Kumi Yamada; Reiji Yoshimura; Jun Nakamura
The effects of a walking intervention on depressive feelings and social adaptation in healthy workers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jun Nakamura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Reiji Yoshimura; Jun Nakamura
[Nicotine dependence and its molecular pharmacology].
Nihon rinsho. Japanese journal of clinical medicine 2013;71(3):473-6.
2013: Atsuko Ikenouchi-Sugita; Asuka Katsuki; Hikaru Hori; Kazuyoshi Saito; Yoshiya Tanaka; Wakako Umene-Nakano; Reiji Yoshimura; Jun Nakamura
Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus.
Human psychopharmacology 2013;28(2):198-202.
2013: Atsuko Ikenouchi-Sugita; Hikaru Hori; Mayumi Sakaue; Kazunari Sugita; Kumi Yamada; Reiji Yoshimura; Jun Nakamura
The effects of a walking intervention on depressive feelings and social adaptation in healthy workers.
Journal of UOEH 2013;35(1):1-8.
2013: Taro Kishi; Shinji Matsunaga; Jun Nakamura; Tomo Okochi; Alessandro Serretti; Wakako Umene-Nakano; Reiji Yoshimura; Christoph Correll; Yasuhisa Fukuo; John M Kane; Nakao Iwata
The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder.
European archives of psychiatry and clinical neuroscience 2013;263(2):105-18.
2013: Wakako Umene-Nakano; Masaru Tateno; Daisuke Fujisawa; Tsutomu Hoshuyama; Takahiro A Kato; Saya Kikuchi; Jun Nakamura
Nationwide survey of work environment, work-life balance and burnout among psychiatrists in Japan.
PloS one 2013;8(2):e55189.
2013: Wakako Umene-Nakano; Reiji Yoshimura; Hikaru Hori; Tatsuya Okamoto; Jun Nakamura
Aripiprazole improves various cognitive and behavioral impairments after traumatic brain injury: a case report.
General hospital psychiatry 2013;35(1):103.e7-9.
2012: Reiji Yoshimura; Wakako Umene-Nakano; Hikaru Hori; Atsuko Ikenouchi-Sugita; Nakao Iwata; Asuka Katsuki; Taro Kishi; Jun Nakamura
Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2012;39(2):355-7.
2012: Masumi Inoue; Hidetada Matsuoka; Jun Nakamura; Keita Harada; Akira Warashina
Mechanisms and roles of muscarinic activation in guinea-pig adrenal medullary cells.
American journal of physiology. Cell physiology 2012;303(6):C635-44.
2012: Asuka Katsuki; Taro Kishi; Wakako Umene-Nakano; Reiji Yoshimura; Kiyokazu Atake; Kenji Hayashi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Nakao Iwata; Jun Nakamura
Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
CNS spectrums 2012;17(3):155-63.
2012: Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Wakako Umene-Nakano; Reiji Yoshimura; Kenji Hayashi; Jun Nakamura
The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
Journal of psychiatric research 2012;46(6):757-61.
2012: Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Wakako Umene-Nakano; Reiji Yoshimura; Kenji Hayashi; Jun Nakamura
Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.
International journal of psychiatry in clinical practice 2012;16(2):138-42.
2012: Reiji Yoshimura; Wakako Umene-Nakano; Kenji Hayashi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Nakao Iwata; Asuka Katsuki; Taro Kishi; Jun Nakamura
No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients.
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2012;10(1):49-53.
2012: Wakako Umene-Nakano; Chiharu Yoshii; Reiji Yoshimura; Kenji Hayashi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Jun Nakamura
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2012;14(4):486-9.
2012: Jun Nakamura
[Early detection and intervention for adjustment disorder and depression in the work place].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 2012;114(9):1093-9.
2012: Naoki Goto; Kenji Hayashi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Shingo Kakeda; Asuka Katsuki; Yukunori Korogi; Junji Moriya; Joji Nishimura; Wakako Umene-Nakano; Reiji Yoshimura; Jun Nakamura
Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia.
Neuropsychiatric disease and treatment 2012;8():119-22.
2012: Takahiro Shinkai; Jun Nakamura
[Antidepressants: clinical guidance of treatment for people with depression and physical health problems].
Nihon rinsho. Japanese journal of clinical medicine 2012;70(1):47-51.
2012: Reiji Yoshimura; Naoki Yunoue; Shintaro Hirata; Kosuke Saito; Kazuyoshi Saitoh; Yoshiya Tanaka; Tadanori Terada; Wakako Umene-Nakano; Jun Nakamura
Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinally.
Annals of general psychiatry 2012;11(1):2.
2012: Reiji Yoshimura; Masaru Tomita; Wakako Umene-Nakano; Kiyokazu Atake; Kenji Hayashi; Hikaru Hori; Atsuko Ikenouchi-Sugita; Asuka Katsuki; Jun Nakamura
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Human psychopharmacology 2012;27(1):33-8.
2011: Reiji Yoshimura; Jun Nakamura
[Effects of smoking and caffeine on pharmacological treatment for patients with schizophrenia and depression].
Nihon Arukōru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 2011;46(6):585-8.
2011: Atsuko Ikenouchi-Sugita; Nakao Iwata; Asuka Katsuki; Taro Kishi; Kenji Hayashi; Hikaru Hori; Nobuhisa Ueda; Wakako Umene-Nakano; Reiji Yoshimura; Jun Nakamura
Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report.
Human psychopharmacology 2011;26(7):531-4.
2011: Atsuko Ikenouchi-Sugita; Nakao Iwata; Asuka Katsuki; Taro Kishi; Kazuyoshi Saito; Yoshiya Tanaka; Wakako Umene-Nakano; Reiji Yoshimura; Hikaru Hori; Jun Nakamura
No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients.
Human psychopharmacology 2011;26(4-5):348-51.
2011: Reiji Yoshimura; Taro Kishi; Akihito Suzuki; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Nakao Iwata; Jun Nakamura
The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
Progress in neuro-psychopharmacology & biological psychiatry 2011;35(4):1022-5.
2011: Hidetada Matsuoka; Keita Harada; Jun Nakamura; Mitsunori Fukuda; Masumi Inoue
Differential distribution of synaptotagmin-1, -4, -7, and -9 in rat adrenal chromaffin cells.
Cell and tissue research 2011;344(1):41-50.
2011: Wakako Umene-Nakano; Naoki Uchida; Takahiro Kato; Masaru Tateno; Ryohei Matsumoto; Jun Nakamura
[Views on the new psychiatric specialist certification system from the perspective of those experiencing the postgraduate psychiatric training system in Japan].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 2011;113(3):271-6.
2011: N Goto; Reiji Yoshimura; Shingo Kakeda; Junji Moriya; K Hayashi; A Ikenouchi-Sugita; W Umene-Nakano; Hikaru Hori; Nobuhisa Ueda; Yukunori Korogi; Jun Nakamura
Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(1):57-63.
2010: Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Junji Moriya; Hikaru Hori; Kenji Hayashi; Atsuko Ikenouchi-Sugita; Wakako Nakano-Umene; Asuka Katsuki; Joji Nishimura; Yukunori Korogi; Jun Nakamura
No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(8):1480-3.
2010: Wakako Umene-Nakano; Reiji Yoshimura; Nobuhisa Ueda; Akihito Suzuki; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Jun Nakamura
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
Journal of psychopharmacology (Oxford, England) 2010;24(12):1764-71.
2010: Reiji Yoshimura; Wakako Umene-Nakano; Tsutomu Hoshuyama; Atsuko Ikenouchi-Sugita; Hikaru Hori; Asuka Katsuki; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.
Human psychopharmacology 2010;25(7-8):566-9.
2010: Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Asuka Katsuki; Kenji Hayashi; Kiyokazu Atake; Nobuhisa Ueda; Jun Nakamura
[Brain-derived neurotrophic factor (BDNF) and mood disorder].
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 2010;30(5-6):181-4.
2010: Reiji Yoshimura; Wakako Umene-Nakano; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Hikaru Hori; Asuka Katsuki; Kenji Hayashi; Kyoko Miyamoto; Yuki Kodama; Jun Nakamura
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.
Human psychopharmacology 2010;25(6):487-90.
2010: Keita Harada; Hidetada Matsuoka; Jun Nakamura; Mitsunori Fukuda; Masumi Inoue
Storage of GABA in chromaffin granules and not in synaptic-like microvesicles in rat adrenal medullary cells.
Journal of neurochemistry 2010;114(2):617-26.
2010: Shinichi Sakata; Takahiro Shinkai; Rudi Hwang; Kensuke Utsunomiya; Kenji Yamada; Hsin-I Chen; Osamu Ohmori; Jun Nakamura
A functional polymorphism (Ser326Cys) of the human 8-oxoguanine DNA glycosylase (hOGG1) gene and schizophrenia.
Psychiatry research 2010;177(1-2):268-9.
2010: Naoki Goto; Reiji Yoshimura; Junji Moriya; Shingo Kakeda; Kenji Hayashi; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Norihiro Oonari; Yukunori Korogi; Jun Nakamura
Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study.
Psychiatry research 2010;182(1):53-7.
2010: Wakako Umene-Nakano; Reiji Yoshimura; Chiharu Yoshii; Tsutomu Hoshuyama; Kenji Hayashi; Hikaru Hori; Asuka Katsuki; Atsuko Ikenouchi-Sugita; Jun Nakamura
Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Human psychopharmacology 2010;25(3):276-9.
2010: Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Asuka Katsuki; Kenji Hayashi; Nobuhisa Ueda; Jun Nakamura
Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(2):308-12.
2010: Reiji Yoshimura; Nobuhisa Ueda; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Jun Nakamura
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):256-61.
2010: Yuichiro Nakano; Reiji Yoshimura; Hideki Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study.
Human psychopharmacology 2010;25(2):139-44.
2010: Junji Moriya; Shingo Kakeda; Osamu Abe; Naoki Goto; Reiji Yoshimura; Hikaru Hori; Norihiro Ohnari; Toru Sato; Shigeki Aoki; Kuni Ohtomo; Jun Nakamura; Yukunori Korogi
Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia.
Schizophrenia research 2010;116(2-3):196-203.
2010: Kazunari Sugita; Kenji Kabashima; Ryutaro Yoshiki; Atsuko Ikenouchi-Sugita; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara; Yoshiki Tokura
Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival.
The Journal of investigative dermatology 2010;130(2):464-71.
2010: Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Kenji Hayashi; Asuka Katsuki; Nobuhisa Ueda; Jun Nakamura
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 2010;112(10):982-5.
2010: Wakako Umene-Nakano; Takahiro Kato; Masaru Tateno; Tsutomu Hoshuyama; Jun Nakamura
[Issues and the current situation of the new compulsory residency training program in Japan: the results of an attitude survey for young career psychiatrists].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 2010;112(4):325-35.
2010: Kensuke Utsunomiya; Takahiro Shinkai; Shinichi Sakata; Rudi Hwang; Kenji Yamada; Hsin-I Chen; Yuko Fukunaka; Osamu Ohmori; Jun Nakamura
Lack of association between the leptin receptor gene (LEPR) Gln223Arg polymorphism and late-onset Alzheimer disease.
Alzheimer disease and associated disorders 2010;24(1):101-3.
2009: Naoki Goto; Reiji Yoshimura; Shingo Kakeda; Junji Moriya; Kenji Hayashi; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Hikaru Hori; Nobuhisa Ueda; Yukunori Korogi; Jun Nakamura
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Human psychopharmacology 2009;24(8):639-45.
2009: Atsuko Ikenouchi-Sugita; Yumiko Toyohira; Reiji Yoshimura; Susumu Ueno; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara
Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex.
Naunyn-Schmiedeberg's archives of pharmacology 2009;380(6):479-86.
2009: Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Hikaru Hori; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(8):1451-3.
2009: Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyamoto; Atsuko Ikenouchi-Sugita; Hikaru Hori; Koichi Otani; Jun Nakamura
Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.
Human psychopharmacology 2009;24(6):489-94.
2009: Wakako Umene-Nakano; Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Kenji Hayashi; Nobuhisa Ueda; Jun Nakamura
Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
Human psychopharmacology 2009;24(5):409-13.
2009: Naoki Goto; Reiji Yoshimura; Junji Moriya; Shingo Kakeda; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Kenji Hayashi; Norihiro Oonari; Yukunori Korogi; Jun Nakamura
Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
Schizophrenia research 2009;112(1-3):192-3.
2009: Reiji Yoshimura; Hikaru Hori; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Nobuhisa Ueda; Jun Nakamura
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(4):722-6.
2009: Wakana Yamaguchi; Takahiro Shinkai; Yoshiaki Inoue; Kensuke Utsunomiya; Shinichi Sakata; Yuko Fukunaka; Kenji Yamada; Hsin-I Chen; Rudi Hwang; Osamu Ohmori; Jun Nakamura
Association analysis between the C-1291G polymorphism in the promoter region of the adrenergic alpha2A receptor gene and polydipsia in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(3):499-502.
2009: Yoshiaki Inoue; Takahiro Shinkai; Kensuke Utsunomiya; Shinichi Sakata; Yuko Fukunaka; Wakana Yamaguchi; Kenji Yamada; Hsin-I Chen; Rudi Hwang; Osamu Ohmori; Jun Nakamura
No association between a functional polymorphism in the promoter region of the neuropeptide Y gene (-485C>T) and schizophrenia.
Neuroscience letters 2009;452(1):72-4.
2009: Hikaru Hori; Nobuhisa Ueda; Reiji Yoshimura; Hiroshi Yamamoto; Kenta Wani; Yoshinori Etoh; Kensuke Haraga; Junichi Kitahara; Jun Nakamura
Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):741-5.
2009: Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Kenji Hayashi; Nobuhisa Ueda; Wakako Umene-Nakano; Hikaru Hori; Jun Nakamura
A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):977-80.
2009: Nobuhisa Ueda; Reiji Yoshimura; Wakako Umene-Nakano; Atsuko Ikenouchi-Sugita; Hikaru Hori; Kenji Hayashi; Yuki Kodama; Jun Nakamura
Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):832-5.
2009: Hikaru Hori; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Wakako Umene-Nakano; Jun Nakamura
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):620-2.
2008: Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Nobuhisa Ueda; Yuki Kodama; Wakako Umene-Nakano; Jun Nakamura
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes.
Neuropsychiatric disease and treatment 2008;4(6):1277-81.
2008: Reiji Yoshimura; Wakako Umene-Nakano; Nobuhisa Ueda; Atsuko Ikenouchi-Sugita; Hikaru Hori; Jun Nakamura
Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline.
Human psychopharmacology 2008;23(8):707-13.
2008: Kensuke Utsunomiya; Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Shinichi Sakata; Yuko Fukunaka; Hsin-I Chen; Osamu Ohmori; Jun Nakamura
Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
Neuroscience letters 2008;444(2):161-5.
2008: Hidetada Matsuoka; Keita Harada; Yutaka Endo; Akira Warashina; Yoshiaki Doi; Jun Nakamura; Masumi Inoue
Molecular mechanisms supporting a paracrine role of GABA in rat adrenal medullary cells.
The Journal of physiology 2008;586(Pt 20):4825-42.
2008: Tatsuya Okamoto; Reiji Yoshimura; Atsuko Ikenouchi-Sugita; Hikaru Hori; Wakako Umene-Nakano; Yoshiaki Inoue; Nobuhisa Ueda; Jun Nakamura
Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(5):1185-90.
2008: Nobuhisa Ueda; Yuki Kodama; Hikaru Hori; Wakako Umene; Atsuko Sugita; Hideki Nakano; Reiji Yoshimura; Jun Nakamura
Two cases of burning mouth syndrome treated with olanzapine.
Psychiatry and clinical neurosciences 2008;62(3):359-61.
2008: Reiji Yoshimura; Shingo Kakihara; Wakako Umene-Nakano; Atsuko Sugita; Hikaru Hori; Nobuhisa Ueda; Jun Nakamura
Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
Human psychopharmacology 2008;23(4):327-32.
2008: Masae Mitoma; Reiji Yoshimura; Atsuko Sugita; Wakako Umene; Hikaru Hori; Hideki Nakano; Nobuhisa Ueda; Jun Nakamura
Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(3):679-85.
2008: Takahiro Shinkai; Vincenzo De Luca; Kensuke Utsunomiya; Shinichi Sakata; Yoshiaki Inoue; Yuko Fukunaka; Rudi Hwang; Osamu Ohmori; James L Kennedy; Jun Nakamura
Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia.
Neuromolecular medicine 2008;10(4):362-7.
2007: Kyoko Miyamoto; Reiji Yoshimura; Nobuhisa Ueda; Atsuko Sugita; Wakako Umene; Hikaru Hori; Masae Mitoma; Jun Nakamura
Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.
Human psychopharmacology 2007;22(7):483-90.
2007: Atsuko Ikenouchi-Sugita; Reiji Yoshimura; Jun Nakamura
[Review of pharmacological efficacies and side effects of antidepressants].
Nihon rinsho. Japanese journal of clinical medicine 2007;65(9):1633-7.
2007: Reiji Yoshimura; Masae Mitoma; Atsuko Sugita; Hikaru Hori; Tatsuya Okamoto; Wakako Umene; Nobuhisa Ueda; Jun Nakamura
Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(5):1034-7.
2007: Reiji Yoshimura; Hikaru Hori; Atsuko Sugita; Nobuhisa Ueda; Shingo Kakihara; Wakako Umene; Yuichiro Nakano; Koji Shinkai; Masae Mitoma; Makiko Ohta; Takahiro Shinkai; Jun Nakamura
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(5):1072-7.
2007: Yui Naoe; Takahiro Shinkai; Hiroko Hori; Yuko Fukunaka; Kensuke Utsunomiya; Shinichi Sakata; Chima Matsumoto; Kazuko Shimizu; Rudi Hwang; Osamu Ohmori; Jun Nakamura
No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis.
Neuroscience letters 2007;415(2):108-12.
2007: Koji Shinkai; Yumiko Toyohira; Reiji Yoshimura; Masato Tsutsui; Susume Ueno; Jun Nakamura; Nobuyuki Yanagihara
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.
Naunyn-Schmiedeberg's archives of pharmacology 2007;375(1):65-72.
2007: Yoshiaki Inoue; Takeshi Terao; N Iwata; K Okamoto; Hideki Kojima; T Okamoto; Reiji Yoshimura; Jun Nakamura
Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
Psychopharmacology 2007;190(2):213-9.
2007: Reiji Yoshimura; Koshiro Tsuji; Nobuhisa Ueda; Jun Nakamura
Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.
Neuropsychiatric disease and treatment 2007;3(5):683-6.
2007: Yuko Fukunaka; Takahiro Shinkai; Rudi Hwang; Hiroko Hori; Kensuke Utsunomiya; Shinichi Sakata; Yui Naoe; Kazuko Shimizu; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia.
Neuromolecular medicine 2007;9(4):292-7.
2007: Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Daniel J Müller; Matthew Lanktree; Gwyneth Zai; Sajid Shaikh; Gregory Wong; Tricia Sicard; Natalia Potapova; Joseph Trakalo; Nicole King; Chima Matsumoto; Hiroko Hori; Albert H C Wong; Osamu Ohmori; Fabio Macciardi; Jun Nakamura; James L Kennedy
Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
Neuromolecular medicine 2007;9(2):169-77.
2007: Reiji Yoshimura; Koji Shinkai; Nobuhisa Ueda; Jun Nakamura
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
Pharmacopsychiatry 2007;40(1):9-13.
2007: Hikaru Hori; Reiji Yoshimura; Yasuhisa Yamada; Atsuko Ikenouchi; Masae Mitoma; Yoshishige Ida; Jun Nakamura
Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.
International clinical psychopharmacology 2007;22(1):21-7.
2006: Reiji Yoshimura; Yuichiro Nakano; Hikaru Hori; Atsuko Ikenouchi; Nobuhisa Ueda; Jun Nakamura
Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.
Human psychopharmacology 2006;21(7):433-8.
2006: Atsuko Ikenouchi; Reiji Yoshimura; Naomi Ikemura; Kensuke Utsunomiya; Masae Mitoma; Jun Nakamura
Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(7):1359-63.
2006: Atsushi Soya; Takeshi Terao; Mami Nakajima; Hideki Kojima; Tatsuya Okamoto; Yoshiaki Inoue; Miki Iwakawa; Koji Shinkai; Reiji Yoshimura; Yoichi Ueta; Jun Nakamura
Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers.
Psychopharmacology 2006;187(4):526-7.
2006: Reiji Yoshimura; Sachiko Kaneko; Koji Shinkai; Jun Nakamura
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Psychiatry and clinical neurosciences 2006;60(3):389-93.
2006: Makiko Goto; Reiji Yoshimura; Shingo Kakihara; Koji Shinkai; Yasuhisa Yamada; Kyoko Kaji; Nobuhisa Ueda; Jun Nakamura
Risperidone in the treatment of psychotic depression.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(4):701-7.
2006: Shuji Soeda; Takeshi Terao; Noboru Iwata; Haruhiko Abe; Kazuhiko Uchida; Jun Nakamura
Mental effect of cholesterol in males: protective effect?
Journal of affective disorders 2006;91(2-3):139-44.
2006: T Yukimasa; Reiji Yoshimura; Akira Tamagawa; Takenori Uozumi; Koji Shinkai; Nobuhisa Ueda; Sadatoshi Tsuji; Jun Nakamura
High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
Pharmacopsychiatry 2006;39(2):52-9.
2006: Takahiro Shinkai; Daniel J Müller; Vincenzo De Luca; Sajid Shaikh; Chima Matsumoto; Rudi Hwang; Nicole King; Joseph Trakalo; Natalia Potapova; Gwyneth Zai; Hiroko Hori; Osamu Ohmori; Herbert Y Meltzer; Jun Nakamura; James L Kennedy
Genetic association analysis of the glutathione peroxidase (GPX1) gene polymorphism (Pro197Leu) with tardive dyskinesia.
Psychiatry research 2006;141(2):123-8.
2006: Chima Matsumoto; Takahiro Shinkai; Vincenzo De Luca; Hiroko Hori; Rudi Hwang; Osamu Ohmori; James L Kennedy; Jun Nakamura
Association study between functional polymorphisms in the cytochrome P450 1A2 and 2D6 genes and polydipsia in schizophrenia.
Neuromolecular medicine 2006;8(3):381-8.
2006: Hiroko Hori; Takahiro Shinkai; Chima Matsumoto; Osamu Ohmori; Jun Nakamura
No association between a functional NAD(P)H: quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia.
Neuromolecular medicine 2006;8(3):375-80.
2006: Hideki Nakano; Takeshi Terao; Takahiro Shinkai; Noboru Iwata; Jun Nakamura
[Risk factors for suicide: a questionnaire survey by psychiatrists in Fukuoka Prefecture].
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 2006;108(1):24-30.
2005: Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Chima Matsumoto; Hiroko Hori; Osamu Ohmori; Gary Remington; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Jun Nakamura; James L Kennedy
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Neuroscience letters 2005;388(2):116-20.
2005: Koji Shinkai; Reiji Yoshimura; Yumiko Toyohira; Susumu Ueno; Masato Tsutsui; Jun Nakamura; Nobuyuki Yanagihara
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells.
Biochemical pharmacology 2005;70(9):1389-97.
2005: Reiji Yoshimura; Koji Shinkai; Yumiko Toyohira; Susumu Ueno; Nobuyuki Yanagihara; Jun Nakamura
Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells.
Human psychopharmacology 2005;20(7):477-84.
2005: Atsushi Soya; Ryota Serino; Hiroaki Fujihara; Tatsushi Onaka; Yumi Ozaki; Takeshi Saito; Jun Nakamura; Yoichi Ueta
Cannabinoids modulate synaptic activity in the rat supraoptic nucleus.
Journal of neuroendocrinology 2005;17(9):609-15.
2005: Chima Matsumoto; Takahiro Shinkai; Vincenzo De Luca; Rudi Hwang; Hiroko Hori; Matthew Lanktree; Osamu Ohmori; James L Kennedy; Jun Nakamura
Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(2):245-53.
2005: Reiji Yoshimura; Jun Nakamura; Koji Shinkai; Makiko Goto; Yasuhisa Yamada; Kyoko Kaji; Shingo Kakihara; Nobuhisa Ueda; Kimio Kohara; Hideaki Ninomiya; Hideaki Egami; Hisao Maeda
An open study of risperidone liquid in the acute phase of schizophrenia.
Human psychopharmacology 2005;20(4):243-8.
2005: Reiji Yoshimura; Koji Shinkai; Shingo Kakihara; Makiko Goto; Yasuhisa Yamada; Kyoko Kaji; Nobuhisa Ueda; Jun Nakamura
Little effects of low dosage of levomepromazine on plasma risperidone levels.
Pharmacopsychiatry 2005;38(2):98-100.
2005: Shingo Kakihara; Reiji Yoshimura; Koji Shinkai; Chima Matsumoto; Makiko Goto; Kyoko Kaji; Yasuhisa Yamada; Nobuhisa Ueda; Osamu Ohmori; Jun Nakamura
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
International clinical psychopharmacology 2005;20(2):71-8.
2005: M Nakajima; T Terao; N Iwata; Jun Nakamura
Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Pharmacopsychiatry 2005;38(1):17-9.
2004: Chima Matsumoto; Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; Jun Nakamura
Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
Psychiatric genetics 2004;14(4):209-13.
2004: Yasuko Shiraishi; Takeshi Terao; Kenji Ibi; Jun Nakamura; Akihiko Tawara
Charles Bonnet syndrome and visual acuity--the involvement of dynamic or acute sensory deprivation.
European archives of psychiatry and clinical neuroscience 2004;254(6):362-4.
2004: Yumi Ozaki; Atsushi Soya; Jun Nakamura; Tetsuro Matsumoto; Yoichi Ueta
Potentiation by angiotensin II of spontaneous excitatory postsynaptic currents in rat supraoptic magnocellular neurones.
Journal of neuroendocrinology 2004;16(11):871-9.
2004: Miki Iwakawa; Takeshi Terao; Atsushi Soya; Hideki Kojima; Yoshiaki Inoue; Nobuhisa Ueda; Reiji Yoshimura; Jun Nakamura
A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.
Psychopharmacology 2004;176(3-4):407-11.
2004: Takahiro Shinkai; Vincenzo De Luca; Gwyneth Zai; Sajid Shaikh; Chima Matsumoto; Paul D Arnold; Rudi Hwang; Nicole King; Joseph Trakalo; Natalia Potapova; Gregory Wong; Hiroko Hori; Albert H C Wong; Osamu Ohmori; Jun Nakamura; James L Kennedy
No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia.
Psychiatric genetics 2004;14(3):177-80.
2004: Reiji Yoshimura; Jun Nakamura; Koji Shinkai; Nobuhisa Ueda
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(4):611-6.
2004: Hideki Nakano; Takeshi Terao; Noboru Iwata; Rina Hasako; Jun Nakamura
Symptomatological and cognitive predictors of insight in chronic schizophrenia.
Psychiatry research 2004;127(1-2):65-72.
2004: Chima Matsumoto; Takahiro Shinkai; Hiroko Hori; Osamu Ohmori; Jun Nakamura
Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Psychiatry research 2004;127(1-2):1-7.
2004: Shuji Soeda; Akiko Kaku; Takeshi Hayashi; Yoichi Sugawara; Jun Nakamura
Differences in mental health consultation between male and female workers in the health care center of a private enterprise.
Journal of UOEH 2004;26(2):207-14.
2004: Yasuko Shiraishi; Takeshi Terao; Kenji Ibi; Jun Nakamura; Akihiko Tawara
The rarity of Charles Bonnet syndrome.
Journal of psychiatric research 2004;38(2):207-13.
2004: Shuji Soeda; Takeshi Terao; Mariko Nishimura; Jun Nakamura; Noboru Iwata
Aging and visual hallucinations in elderly psychiatric outpatients.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(2):401-4.
2004: Koji Shinkai; Reiji Yoshimura; Nobuhisa Ueda; Kana Okamoto; Jun Nakamura
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment.
Journal of clinical psychopharmacology 2004;24(1):11-7.
2004: Takahiro Shinkai; Osamu Ohmori; Chima Matsumoto; Hiroko Hori; James L Kennedy; Jun Nakamura
Genetic association analysis of neuronal nitric oxide synthase gene polymorphism with tardive dyskinesia.
Neuromolecular medicine 2004;5(2):163-70.
2004: Mariko Nishimura; Takeshi Terao; Shuji Soeda; Jun Nakamura; Noboru Iwata; Kaoru Sakamoto
Suicide and occupation: further supportive evidence for their relevance.
Progress in neuro-psychopharmacology & biological psychiatry 2004;28(1):83-7.
2003: Nobuhisa Ueda; Takeshi Terao; Osamu Ohmori; Jun Nakamura
Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
Human psychopharmacology 2003;18(6):477-8.
2003: Mami Nakajima; Takeshi Terao; Jun Nakamura
Characteristics of repeatedly secluded elderly female schizophrenic inpatients.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(5):771-4.
2003: Hiroko Hori; Osamu Ohmori; Chima Matsumoto; Takahiro Shinkai; Jun Nakamura
NAD(P)H: quinone oxidoreductase (NQO1) gene polymorphism and schizophrenia.
Psychiatry research 2003;118(3):235-9.
2003: Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; Chima Matsumoto; Jun Nakamura
A perspective on molecular genetic studies of tardive dyskinesia: one clue for individualized antipsychotic drug therapy.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(4):581-6.
2003: Takahiro Shinkai; Osamu Ohmori; Hiroko Hori; Jun Nakamura
Genetic approaches to polydipsia in schizophrenia: a preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;119B(1):7-12.
2003: Shuji Soeda; Takeshi Hayashi; Yoichi Sugawara; Tomoki Takano; Takeshi Terao; Jun Nakamura
A comparison of white-collar jobs in regard to mental health consultation rates in a health care center operated by a Japanese company.
Industrial health 2003;41(2):117-9.
2003: Hideki Kojima; Takeshi Terao; Miki Iwakawa; Atsushi Soya; N Inoue; Y Shiraishi; Y Son; S Soeda; Nobuhisa Ueda; Reiji Yoshimura; Jun Nakamura
Paroxetine as a 5-HT neuroendocrine probe.
Psychopharmacology 2003;167(1):97-102.
2003: Reiji Yoshimura; Nobuhisa Ueda; Koji Shinkai; Jun Nakamura
Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia.
International clinical psychopharmacology 2003;18(2):107-11.
2003: Chima Matsumoto; Jun Nakamura
[Other sedatives and hypnotics-related disorders].
Ryōikibetsu shōkōgun shirīzu 2003;(40):497-500.
2003: Hideki Kojima; Yoshimasa Inoue; Jun Nakamura
[Barbiturate-related disorders].
Ryōikibetsu shōkōgun shirīzu 2003;(40):493-6.
2003: Shinichi Sakata; Jun Nakamura
[Delirium tremens].
Ryōikibetsu shōkōgun shirīzu 2003;(40):432-6.
2003: Nobuhisa Ueda; Reiji Yoshimura; Koji Shinkai; Yumi Sakata; Jun Nakamura
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.
Neuropsychobiology 2003;48(1):31-4.
2003: Koji Shinkai; Jun Nakamura
[Premonitory depression].
Ryōikibetsu shōkōgun shirīzu 2003;(38):334-6.
2003: Kyoko Kaji; Reiji Yoshimura; Jun Nakamura
[Double depression].
Ryōikibetsu shōkōgun shirīzu 2003;(38):328-33.
2002: Atsushi Soya; Takeshi Terao; Jun Nakamura
Effects of lithium addition on daily activity and psychiatric symptoms in schizophrenic inpatients.
Journal of UOEH 2002;24(4):391-5.
2002: Yukiyo Izumi; Takeshi Terao; Yoichi Ishino; Jun Nakamura
Differences in regional cerebral blood flow during musical and verbal hallucinations.
Psychiatry research 2002;116(1-2):119-23.
2002: Nobuhisa Ueda; Reiji Yoshimura; Koji Shinkai; Jun Nakamura
Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
Pharmacopsychiatry 2002;35(5):175-81.
2002: Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; Jun Nakamura
Genetic association analysis of 5-HT(6) receptor gene polymorphism (267C/T) with tardive dyskinesia.
Psychiatry research 2002;110(2):97-102.
2002: Chima Matsumoto; Osamu Ohmori; Hiroko Hori; Takahiro Shinkai; Jun Nakamura
Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans.
Neuroscience letters 2002;321(3):165-8.
2002: Takahiro Shinkai; Osamu Ohmori; Hiroko Hori; Jun Nakamura
Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia.
Molecular psychiatry 2002;7(6):560-3.
2002: Reiji Yoshimura; Nobuhisa Ueda; Jun Nakamura; Seiji Eto; Masakazu Matsushita
Interaction between fluvoxamine and cotinine or caffeine.
Neuropsychobiology 2002;45(1):32-5.
2001: Hiroko Hori; Osamu Ohmori; Takahiro Shinkai; H Kojima; Jun Nakamura
Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
American journal of medical genetics 2001;105(8):774-8.
2001: S Soeda; Jun Nakamura
[Depression].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 8():400-5.
2001: Nobuhisa Ueda; Reiji Yoshimura; Koji Shinkai; Takeshi Terao; Jun Nakamura
Characteristics of fluvoxamine-induced nausea.
Psychiatry research 2001;104(3):259-64.
2001: Jun Nakamura; Reiji Yoshimura; T Okuno; Nobuhisa Ueda; M Hachida; Kosei Yasumoto; H Egami; H Maeda; M Nishi; S Aoyagi
Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients.
International clinical psychopharmacology 2001;16(6):339-43.
2001: Reiji Yoshimura; Shingo Kakihara; Atsushi Soya; Nobuhisa Ueda; Koji Shinkai; Jun Nakamura
Effect of clonazepam treatment on antipsychotic drug-induced Meige syndrome and changes in plasma levels of GABA, HVA, and MHPG during treatment.
Psychiatry and clinical neurosciences 2001;55(5):543-6.
2001: Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; Jun Nakamura
Novel polymorphism in the 5'-upstream region of the human 5-HT6 receptor gene and schizophrenia.
Neuroscience letters 2001;310(1):17-20.
2001: Nobuhisa Ueda; Jun Nakamura
[Side effects and its countermeasures of antidepressant].
Nihon rinsho. Japanese journal of clinical medicine 2001;59(8):1535-8.
2001: Hikaru Hori; Takeshi Terao; Jun Nakamura
Charles Bonnet syndrome with auditory hallucinations: a diagnostic dilemma.
Psychopathology 2001;34(3):164-6.
2001: H Hori; Reiji Yoshimura; Jun Nakamura
Increased libido in a woman treated with fluvoxamine: a case report.
Acta psychiatrica Scandinavica 2001;103(4):312-4.
2001: Hiroko Hori; Osamu Ohmori; Takahiro Shinkai; H Kojima; Jun Nakamura
Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia.
American journal of medical genetics 2001;105(2):176-8.
2001: Hiroko Hori; Osamu Ohmori; Takahiro Shinkai; H Kojima; Jun Nakamura
Clara cell secretory protein (CC16) gene polymorphism and schizophrenia in humans.
Neuroscience letters 2001;298(1):75-7.
2001: Reiji Yoshimura; Nobuhisa Ueda; Jun Nakamura
Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study.
Neuropsychobiology 2001;44(3):129-33.
2000: Takahiro Shinkai; Osamu Ohmori; T Suzuki; H Kojima; Hiroko Hori; T Terao; Jun Nakamura
Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: an association study.
Psychiatric genetics 2000;10(4):165-71.
2000: Nobuhisa Ueda; Reiji Yoshimura; S Eto; Takeshi Terao; Jun Nakamura
Delirious episodes induced by intravenous administration of clomipramine associated with an acute increase in its plasma concentrations.
Psychiatry and clinical neurosciences 2000;54(6):669-72.
2000: Takeshi Terao; Jun Nakamura; Reiji Yoshimura; Osamu Ohmori; N Takahashi; H Kojima; S Soeda; Takahiro Shinkai; Hideki Nakano; T Okuno
Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women.
Psychiatry research 2000;96(2):167-73.
2000: Hiroko Hori; Osamu Ohmori; Takahiro Shinkai; H Kojima; C Okano; T Suzuki; Jun Nakamura
Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(2):170-7.
2000: Reiji Yoshimura; Nobuhisa Ueda; Jun Nakamura
Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine.
International clinical psychopharmacology 2000;15(4):233-5.
2000: H Hori; Takeshi Terao; Jun Nakamura
Visual perseveration: a new side effect of maprotiline.
Acta psychiatrica Scandinavica 2000;101(6):476-7.
2000: Reiji Yoshimura; Jun Nakamura; Nobuhisa Ueda; Takeshi Terao
Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement.
International clinical psychopharmacology 2000;15(3):175-80.
2000: Reiji Yoshimura; Nobuyuki Yanagihara; K Hara; Takeshi Terao; Jun Nakamura; Susumu Ueno; Yumiko Toyohira; Yasuhito Uezono; S Kaneko; M Kawamura; K Abe; Futoshi Izumi
Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells.
Psychopharmacology 2000;149(1):17-23.
2000: Hikaru Hori; Takeshi Terao; Yasuko Shiraishi; Jun Nakamura
Treatment of Charles Bonnet syndrome with valproate.
International clinical psychopharmacology 2000;15(2):117-9.
2000: Osamu Ohmori; Takahiro Shinkai; T Suzuki; C Okano; H Kojima; T Terao; Jun Nakamura
Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study.
American journal of medical genetics 2000;96(1):118-22.
2000: Osamu Ohmori; Takahiro Shinkai; Hiroko Hori; H Kojima; Jun Nakamura
Synapsin III gene polymorphisms and schizophrenia.
Neuroscience letters 2000;279(2):125-7.
2000: Takeshi Terao; Jun Nakamura; Reiji Yoshimura; Osamu Ohmori; N Takahashi; T Shinkai
Prediction of lithium response using. m-chlorophenylpiperazine challenge test: A preliminary finding.
International clinical psychopharmacology 2000;15(1):39-42.
1999: Shuji Soeda; Takeshi Terao; Jun Nakamura
[The influence of clomipramine-induced mania on rapid cycling affective disorder].
Journal of UOEH 1999;21(4):309-15.
1999: Takeshi Terao; H Hori; Jun Nakamura
[L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
Ryōikibetsu shōkōgun shirīzu 1999;(27 Pt 2):650-3.
1998: Takahiro Shinkai; Osamu Ohmori; H Kojima; T Terao; T Suzuki; K Abe; Jun Nakamura
Apolipoprotein E regulatory region genotype in schizophrenia.
Neuroscience letters 1998;256(1):57-60.